Birdwatch Note
2024-12-17 23:35:14 UTC - NOT_MISLEADING
Trump's model (from 2021 through 2023) had less than half Part D plans chose to participate. CMS estimates that around 800,000 people had access to $35 insulin copays. Under Biden’s Inflation Reduction Act, $35 insulin was available to an estimated 3.3 million. https://www.kff.org/policy-watch/the-facts-about-the-35-insulin-copay-cap-in-medicare/
Written by 3362CA605346945375970CE797080971AC82326B903EFB5C3376CBAB74AC086B
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1869043047419240475
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1869164479692292134
- noteId - 1869164479692292134
- participantId -
- noteAuthorParticipantId - 3362CA605346945375970CE797080971AC82326B903EFB5C3376CBAB74AC086B Participant Details
- createdAtMillis - 1734478514012
- tweetId - 1869043047419240475
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Trump's model (from 2021 through 2023) had less than half Part D plans chose to participate. CMS estimates that around 800,000 people had access to $35 insulin copays. Under Biden’s Inflation Reduction Act, $35 insulin was available to an estimated 3.3 million. https://www.kff.org/policy-watch/the-facts-about-the-35-insulin-copay-cap-in-medicare/
Note Ratings
| rated at | rated by | |
| 2024-12-18 12:19:19 -0600 | Rating Details | |
| 2024-12-18 11:57:45 -0600 | Rating Details | |
| 2024-12-18 09:07:16 -0600 | Rating Details | |
| 2024-12-17 22:13:41 -0600 | Rating Details | |
| 2024-12-17 19:56:03 -0600 | Rating Details | |
| 2024-12-17 18:13:23 -0600 | Rating Details | |
| 2024-12-17 17:45:50 -0600 | Rating Details | |
| 2024-12-18 19:27:18 -0600 | Rating Details | |
| 2024-12-18 12:00:49 -0600 | Rating Details | |
| 2024-12-18 09:15:22 -0600 | Rating Details | |
| 2024-12-17 20:49:37 -0600 | Rating Details | |
| 2024-12-17 18:04:39 -0600 | Rating Details | |
| 2024-12-18 17:52:53 -0600 | Rating Details | |
| 2024-12-18 16:27:20 -0600 | Rating Details | |
| 2024-12-18 14:05:09 -0600 | Rating Details | |
| 2024-12-18 09:32:32 -0600 | Rating Details | |
| 2024-12-17 21:28:18 -0600 | Rating Details | |
| 2024-12-17 19:35:21 -0600 | Rating Details | |
| 2024-12-17 18:35:31 -0600 | Rating Details | |
| 2024-12-17 18:35:01 -0600 | Rating Details | |
| 2024-12-17 18:31:30 -0600 | Rating Details | |
| 2024-12-18 08:55:02 -0600 | Rating Details | |
| 2024-12-17 18:23:37 -0600 | Rating Details |